NSG124 / NSG 124 EXAM 1 PHARMACOLOGY
2026–2027 | HERZING UNIVERSITY STUDY
GUIDE, PRACTICE QUESTIONS, VERIFIED
ANSWERS & DETAILED RATIONALES FOR
EXAM SUCCESS
• This 200-question practice exam covers all core NSG124 Pharmacology topics
tested at Herzing University — use it by attempting each question independently
before revealing the correct answer and EXPERT RATIONALE beneath it.
• Each question features five lettered options (A–E), a bolded correct answer, and a
detailed EXPERT RATIONALE to reinforce understanding and build exam
confidence.
1. Which of the following best describes pharmacokinetics?
A. The study of how drugs produce their effects on the body
B. The study of drug interactions with receptors
C. The study of how the body absorbs, distributes, metabolizes, and excretes drugs
D. The study of adverse drug reactions
E. The study of drug-receptor binding affinity
Correct Answer: C. The study of how the body absorbs, distributes,
metabolizes, and excretes drugs
EXPERT RATIONALE: Pharmacokinetics refers to what the body does to a drug —
encompassing absorption, distribution, metabolism, and excretion (ADME).
Pharmacodynamics, by contrast, is what the drug does to the body.
2. A patient is prescribed a drug with a narrow therapeutic index. This means:
A. The drug has very few side effects
B. The drug is effective only in elderly patients
C. The difference between the therapeutic dose and the toxic dose is small
,D. The drug requires no monitoring
E. The drug is absorbed slowly
Correct Answer: C. The difference between the therapeutic dose and the toxic
dose is small
EXPERT RATIONALE: A narrow therapeutic index means there is little margin
between the dose that produces the desired effect and the dose that causes
toxicity. These drugs require close monitoring (e.g., warfarin, digoxin, lithium).
3. Which route of drug administration provides 100% bioavailability?
A. Oral
B. Sublingual
C. Intramuscular
D. Intravenous
E. Transdermal
Correct Answer: D. Intravenous
EXPERT RATIONALE: Intravenous (IV) administration delivers the drug directly into
the bloodstream, bypassing the first-pass effect and achieving 100% bioavailability.
Other routes are subject to absorption barriers and metabolism.
4. The first-pass effect refers to:
A. The initial absorption of a drug through the skin
B. Metabolism of a drug by the liver before it reaches systemic circulation
C. The excretion of a drug through the kidneys after first use
D. The binding of a drug to plasma proteins on first exposure
E. Rapid distribution of a drug to peripheral tissues
,Correct Answer: B. Metabolism of a drug by the liver before it reaches
systemic circulation
EXPERT RATIONALE: The first-pass effect (first-pass metabolism) occurs when an
orally administered drug is absorbed from the GI tract and passes through the
portal circulation to the liver, where it is partially metabolized before reaching
systemic circulation, reducing its bioavailability.
5. A drug that is a "prodrug" is best described as:
A. A drug that is immediately active upon administration
B. A drug that is inactive until metabolized into its active form
C. A drug that has no side effects
D. A drug administered only intravenously
E. A drug that binds irreversibly to its receptor
Correct Answer: B. A drug that is inactive until metabolized into its active
form
EXPERT RATIONALE: Prodrugs are pharmacologically inactive compounds that are
converted into their active metabolite in the body, usually by hepatic metabolism.
An example is codeine, which is converted to morphine.
6. Which of the following best describes the half-life of a drug?
A. The time for the drug to reach peak plasma concentration
B. The time required for the body to eliminate half of the administered dose
C. The duration of the drug's therapeutic effect
D. The time for the drug to be completely absorbed
E. The time required for the drug to bind to its receptor
, Correct Answer: B. The time required for the body to eliminate half of the
administered dose
EXPERT RATIONALE: Half-life (t½) is the time it takes for the plasma concentration
of a drug to decrease by 50%. It determines dosing intervals and time to steady
state (approximately 4–5 half-lives).
7. Which of the following describes an agonist?
A. A drug that binds to a receptor and blocks its activity
B. A drug that binds to a receptor and produces a biological response
C. A drug that has no affinity for any receptor
D. A drug that only works in the presence of another drug
E. A drug that prevents receptor synthesis
Correct Answer: B. A drug that binds to a receptor and produces a biological
response
EXPERT RATIONALE: An agonist binds to a receptor and activates it, mimicking the
effect of the endogenous ligand. An antagonist, by contrast, binds but does not
activate the receptor, blocking the action of agonists.
8. A competitive antagonist works by:
A. Permanently destroying the receptor
B. Competing with the agonist for the same receptor binding site and can be
overcome with higher agonist doses
C. Activating a different receptor to block the agonist's effect
D. Increasing the metabolism of the agonist
E. Reducing the number of available receptors
2026–2027 | HERZING UNIVERSITY STUDY
GUIDE, PRACTICE QUESTIONS, VERIFIED
ANSWERS & DETAILED RATIONALES FOR
EXAM SUCCESS
• This 200-question practice exam covers all core NSG124 Pharmacology topics
tested at Herzing University — use it by attempting each question independently
before revealing the correct answer and EXPERT RATIONALE beneath it.
• Each question features five lettered options (A–E), a bolded correct answer, and a
detailed EXPERT RATIONALE to reinforce understanding and build exam
confidence.
1. Which of the following best describes pharmacokinetics?
A. The study of how drugs produce their effects on the body
B. The study of drug interactions with receptors
C. The study of how the body absorbs, distributes, metabolizes, and excretes drugs
D. The study of adverse drug reactions
E. The study of drug-receptor binding affinity
Correct Answer: C. The study of how the body absorbs, distributes,
metabolizes, and excretes drugs
EXPERT RATIONALE: Pharmacokinetics refers to what the body does to a drug —
encompassing absorption, distribution, metabolism, and excretion (ADME).
Pharmacodynamics, by contrast, is what the drug does to the body.
2. A patient is prescribed a drug with a narrow therapeutic index. This means:
A. The drug has very few side effects
B. The drug is effective only in elderly patients
C. The difference between the therapeutic dose and the toxic dose is small
,D. The drug requires no monitoring
E. The drug is absorbed slowly
Correct Answer: C. The difference between the therapeutic dose and the toxic
dose is small
EXPERT RATIONALE: A narrow therapeutic index means there is little margin
between the dose that produces the desired effect and the dose that causes
toxicity. These drugs require close monitoring (e.g., warfarin, digoxin, lithium).
3. Which route of drug administration provides 100% bioavailability?
A. Oral
B. Sublingual
C. Intramuscular
D. Intravenous
E. Transdermal
Correct Answer: D. Intravenous
EXPERT RATIONALE: Intravenous (IV) administration delivers the drug directly into
the bloodstream, bypassing the first-pass effect and achieving 100% bioavailability.
Other routes are subject to absorption barriers and metabolism.
4. The first-pass effect refers to:
A. The initial absorption of a drug through the skin
B. Metabolism of a drug by the liver before it reaches systemic circulation
C. The excretion of a drug through the kidneys after first use
D. The binding of a drug to plasma proteins on first exposure
E. Rapid distribution of a drug to peripheral tissues
,Correct Answer: B. Metabolism of a drug by the liver before it reaches
systemic circulation
EXPERT RATIONALE: The first-pass effect (first-pass metabolism) occurs when an
orally administered drug is absorbed from the GI tract and passes through the
portal circulation to the liver, where it is partially metabolized before reaching
systemic circulation, reducing its bioavailability.
5. A drug that is a "prodrug" is best described as:
A. A drug that is immediately active upon administration
B. A drug that is inactive until metabolized into its active form
C. A drug that has no side effects
D. A drug administered only intravenously
E. A drug that binds irreversibly to its receptor
Correct Answer: B. A drug that is inactive until metabolized into its active
form
EXPERT RATIONALE: Prodrugs are pharmacologically inactive compounds that are
converted into their active metabolite in the body, usually by hepatic metabolism.
An example is codeine, which is converted to morphine.
6. Which of the following best describes the half-life of a drug?
A. The time for the drug to reach peak plasma concentration
B. The time required for the body to eliminate half of the administered dose
C. The duration of the drug's therapeutic effect
D. The time for the drug to be completely absorbed
E. The time required for the drug to bind to its receptor
, Correct Answer: B. The time required for the body to eliminate half of the
administered dose
EXPERT RATIONALE: Half-life (t½) is the time it takes for the plasma concentration
of a drug to decrease by 50%. It determines dosing intervals and time to steady
state (approximately 4–5 half-lives).
7. Which of the following describes an agonist?
A. A drug that binds to a receptor and blocks its activity
B. A drug that binds to a receptor and produces a biological response
C. A drug that has no affinity for any receptor
D. A drug that only works in the presence of another drug
E. A drug that prevents receptor synthesis
Correct Answer: B. A drug that binds to a receptor and produces a biological
response
EXPERT RATIONALE: An agonist binds to a receptor and activates it, mimicking the
effect of the endogenous ligand. An antagonist, by contrast, binds but does not
activate the receptor, blocking the action of agonists.
8. A competitive antagonist works by:
A. Permanently destroying the receptor
B. Competing with the agonist for the same receptor binding site and can be
overcome with higher agonist doses
C. Activating a different receptor to block the agonist's effect
D. Increasing the metabolism of the agonist
E. Reducing the number of available receptors
